Context Therapeutics Reports First Quarter 2025 Operating and Financial Results

Go back to Context Therapeutics Reports First Quarter 2025 Operating and Financial Results
(NASDAQ: CNTX) Delayed: 0.48 +0.01 (2.13%)
Previous Close $0.47    52 Week High
Open $0.48    52 Week Low
Day High $0.48    P/E N/A 
Day Low $0.45    EPS
Volume 973,707